Psychoactive drugs in the Brazilian public health system: use profile and associated factors
Author
dc.contributor.author
Siani-Morello, Manuela Roque
Author
dc.contributor.author
Borges Pereira, Lucas
Author
dc.contributor.author
de Lima Ferreira, Iahel Manon
Author
dc.contributor.author
Jirón Aliste, Marcela Carolina
Author
dc.contributor.author
Leira Pereira, Leonardo Régis
Admission date
dc.date.accessioned
2023-04-06T14:52:52Z
Available date
dc.date.available
2023-04-06T14:52:52Z
Publication date
dc.date.issued
2022
Cita de ítem
dc.identifier.citation
Braz. J. Pharm. Sci. 2022;58: e19739
es_ES
Identifier
dc.identifier.other
10.1590/s2175-97902022e19739
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/192574
Abstract
dc.description.abstract
The purpose of this study is to estimate the prevalence of and characterize the use of psychoactive
drugs among drug users in a Brazilian municipality, relating the findings to factors associated
with the consumption of these substances. Through a cross-sectional design, 1,355 drug users
from the public health systems community pharmacies were interviewed. Sociodemographic
and health-related data were collected, as well as any other prescribed drugs. The prevalence
of psychoactive drug use within the last month was 31.0%, with antidepressants and
benzodiazepines being the most prescribed (53.5% and 24.6% respectively). Most psychoactive
drug users were female (81.9%), lived with a partner (52.6%), had private health insurance
(69.2%) and a monthly per-capita income up to one minimum wage (54.0%). The adjusted
Odds Ratio (OR) confirmed the following factors to be positively associated with the use of
psychoactive drugs: female gender (OR=2.06; 95% CI 1.44; 2.95), age ≥60 years old (OR=1.77;
95% CI 1.26; 2.48), follow-up with a psychologist (OR=4.12; 95% CI 1.84; 5.25), absence of
regular physical activity (OR=1.59; 95% CI 1.13; 2.23), and smokers (OR=1.94; 95% CI 1.26;
2.97). Approximately one out of three individuals used at least one psychoactive drug. Health
managers should focus the planning and actions aimed at their rational use for these groups,
leading to increased overall treatment success.
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
Univ Sao Paulo, Conjunto Quimicas, Servico Publicacoes e Circulacao, Brazil
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States